Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCG2 is an efflux transporter that actively pumps a wide variety of substrates across cellular membranes using energy from ATP hydrolysis. It plays a significant role in multidrug resistance in cancer cells, protects tissues from xenobiotics, regulates drug bioavailability, excretes urate, secretes vitamins, and carries the Jr(a) antigen. Targeted therapeutics are under development to inhibit ABCG2 function for overcoming drug resistance in oncology settings.
Efflux of substrates from cells via ATP hydrolysis; inhibition of ABCG2 function to overcome drug resistance
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP Binding Cassette Transporter Subfamily G Member 2 (ABCG2).